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Toxin translocationtoxin catalytic subunit may be a common property of toxins that exit the
endoplasmic reticulum (ER) by exploiting the mechanism of ER-associated degradation (ERAD). The Hae-
mophilus ducreyi cytolethal distending toxin (HdCDT) does not utilize ERAD to exit the ER, so we predicted
the structural properties of its catalytic subunit (HdCdtB) would differ from other ER-translocating toxins.
Here, we document the heat-stable properties of HdCdtB which distinguish it from other ER-translocating
toxins. Cell-based assays further suggested that HdCdtB does not unfold before exiting the ER and that it may
move directly from the ER lumen to the nucleoplasm. These observations suggest a novel mode of ER exit for
HdCdtB.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
The Haemophilus ducreyi cytolethal distending toxin (HdCDT) is an
AB-type genotoxin that consists of a catalytic A moiety (HdCdtB) and a
cell-binding B moiety (HdCdtA+HdCdtC) [1]. Like many AB toxins,
HdCDT must travel from the plasma membrane to the endoplasmic
reticulum (ER) before its A moiety can escape the endomembrane
system to reach its target [2,3]. Translocation of the A chain from the
ER to the cytosol is thought to involve the ER-associated degradation
(ERAD) quality control system [4,5], but HdCDT intoxication is not
inhibited by alterations to ERAD that generate resistance against ﬁve
other ER-translocating toxins: Pseudomonas aeruginosa exotoxin A,
Escherichia coli heat-labile toxin IIb, cholera toxin (CT), plasmid-
encoded toxin, and ricin [3,6–9]. Thus, exit of HdCdtB from the ER
occurs by an ERAD-independent mechanism or by an ERAD mechan-
ism that is signiﬁcantly different from the pathway utilized by many
other ER-translocating toxins. HdCDT is also unique in that it mustsm; CDT, cytolethal distending
reticulum-associated degrada-
s ducreyi cytolethal distending
rtussis toxin
ex, 12722 Research Parkway,
+1 407 384 2062.
l rights reserved.reach the nucleus in order to function whereas other ER-translocating
toxins act in the cytosol.
ERAD-mediated toxin translocation may depend upon the heat-
labile nature of the isolated toxin A chain. The catalytic CTA1
polypeptide, the A subunit of pertussis toxin (PT S1), and ricin A
chain are all in partially or fully unfolded states at near-physiological
temperatures [10–12]. However, thermal instability is not apparent
when the toxin A chain is present in a holotoxin [13–15]. A/B subunit
dissociation, an event that occurs in the ER translocation site, could
thus serve as the trigger for toxin unfolding. This structural shift
would identify the toxin A chain as a misfolded protein and would
thereby promote its ERAD-mediated export into the cytosol. Most
ERAD substrates are rapidly degraded in the cytosol by the ubiquitin-
26S proteasome system, but the A chains of ER-translocating toxins
are thought to avoid this fate because they have a paucity of the lysine
residues that serve as ubiquitin attachment sites [4]. The translocated
A chains may instead be degraded by a relatively slow, ubiquitin-
independent mechanism involving the core 20S proteasome
[11,12,16].
The distinctive nature of the HdCDT translocation mechanism
suggested that HdCdtB may not exhibit the same physical character-
istics observed for the A chains of other ER-translocating toxins. To test
this prediction, biophysical and biochemical experiments were
performed on the puriﬁed HdCdtB protein. We found that, in contrast
to the A chains of other ER-translocating toxins, HdCdtB was heat-
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assays further suggested that HdCdtB does not unfold before exiting
the ER and that it may move directly from the ER lumen to the
nucleoplasm. These results highlight the distinctive nature of CDT and
suggest the cellular processing of HdCdtB differs from host–toxin
interactions involving other ER-translocating toxins.2. Materials and methods
2.1. Biophysical studies
HdCdtB was puriﬁed from E. coli transformed with a glutathione S-
transferase (GST)-CdtB expression vector as previously described [17].
After removal of the GST tag, biophysical measurements were
performed on 0.15 mg HdCdtB in 0.2 ml 10 mM Hepes (pH 7.0) with
1 mM CaCl2 as described [11]. For ﬂuorescence measurements, the
samples were excited at 280 nm and emission spectra recorded
between 300 to 400 nm. For circular dichroism (CD) measurements,
ellipticity, θ, was measured between 200 nm and 250 nm using a J-810
spectroﬂuoropolarimeter (Jasco Corp., Tokyo, Japan). After subtracting
the spectra of the buffer, the mean residue molar ellipticity was
calculated as [θ]=θ /ncl, where θ is the measured ellipticity in
millidegrees, n is the number of residues per molecule, c is the
molar concentration, and l is the optical path-length in mm. The
temperature dependencies of the maximum ﬂuorescence emission
wavelengths or the ellipticities were ﬁtted with theoretical curves as
described previously [11].
2.2. Degradation assays
The protease sensitivity assay and the 20S proteasome assay were
performed as previously described [11]. The CTA1/CTA2 heterodimer
was purchased from Calbiochem (La Jolla, CA); thermolysin was
purchased from Sigma-Aldrich (St. Louis, MO); and the 20S protea-
some was purchased from Boston Biochem (Cambridge, MA).
2.3. Toxicity assays
The assay for HdCDT induction of H2AX phosphorylation was
performed as previously described [18]. HdCDT was reconstituted
from individual subunits as described in [3]. The 2 μg/ml concentra-
tion of HdCDT used for this assay represents the minimal amount of
toxin required to elicit an effect in 100% of the cells after 2 h of
intoxication. Toxicity assays with ricin (Vector Laboratories, Burlin-
game, CA) were based upon the toxin-induced inhibition of protein
synthesis as described in [16].
2.4. Construction of CdtB-CVIM
A C-terminal extension containing the -CVIM farnesylation site
was introduced into CdtB using the cdtB nucleotide sequence from the
pGEX-CdtB-sulf1 plasmid [3] as a template. The following primers
were used:
5′-ATTCGGATCCAACTTGAGTGACTTCAAAGTAGC-3′ and 5′-
TACCGAATTCTCACATGATCACACACCCAGATGGGTATTCGTAGTCTTCTG-
CGCTGCGATCACGAACAAAACTAAC-3′
The PCR fragment was cloned into the BamHI and EcoRI restriction
sites of the pGEX4T3 expression vector (GE Healthcare, Piscataway,
NJ). Puriﬁcation of the fusion protein produced in E. coli strain BL21Fig. 1. HdCdtB thermal stability. Temperature-induced changes to the structure of
HdCdtB were monitored by ﬂuorescence spectroscopy (A, B) and far-UV CD (C). Both
measurements were conducted near-simultaneously on the same sample after
equilibration at each temperature for 3 min. Three scans per spectra were collected
and averaged to improve the signal-to-noise ratio. (A) The change in color from blue to
red corresponds to a step-wise increase in temperature from 18 °C to 60 °C. Dotted lines
are spectra of samples cooled to 50 °C, 40 °C, 37 °C, 25 °C, and 18 °C after HdCdtB was
heated to 60 °C; colors indicate the same temperatures as the solid lines. (B) The
maximum emission wavelengths (λmax) from panel A were plotted as a function of
temperature. Data points from the cooled HdCdtB spectra are presented as open circles.
(C) For far-UV CD analysis, the mean residue molar ellipticities at 220 nm ([θ]220) were
plotted as a function of temperature. Data points from the cooled HdCdtB spectra are
presented as open circles. The solid lines in panels B and C are best ﬁt curves simulated
as described in Ref. [11].
Fig. 2. HdCdtB proteolysis. (A) HdCdtB or the CTA1/CTA2 heterodimer was placed in
20 mM Na-phosphate buffer (pH 7.0) containing 10 mM β-mercaptoethanol. After
incubation at the indicated temperatures for 45 min, thermolysin was added for an
additional 45 min at 4 °C. Proteolysis was halted by the addition of EDTA and sample
buffer. The toxins were then visualized by SDS-PAGE and Coomassie staining. For both
gels, the upper thermolysin band is denoted with an asterisk. (B) HdCdtB or the reduced
CTA1/CTA2 heterodimer was placed in assay buffer with 100 nM of the 20S proteasome.
Proteolysis was halted after 0, 4, 8, or 20 h of incubation at 37 °C. The toxins were then
visualized by SDS-PAGE and Coomassie staining.
491L. Guerra et al. / Biochimica et Biophysica Acta 1793 (2009) 489–495DE3 was performed according to the instructions of the manufacturer
(GE Healthcare).
2.5. Farnesylation assays
Detergent phase partitioning of lysates from cells exposed for 4 h
to 50 μg/ml of a CDT holotoxin containing the GST-CdtB-CVIM subunit
was performed as previously described [19]. GST-CdtB-CVIM was
recovered from aqueous and detergent phases of the lysates by afﬁnity
puriﬁcationwith glutathione sepharose 4B for 1 h at 4 °C.Western blot
was then performed using a horse radish peroxidase-conjugated anti-
GST antibody (Novus Biologicals, Littleton, CO). In vitro farnesylation
of GST-CdtB-CVIM was demonstrated by mixing 5 μg of the protein
with 35 μl rabbit reticulocyte lysate (Sigma-Aldrich), 1 mMMgCl2, and
5 mM farnesyl pyrophosphate (Sigma-Aldrich) for 1 h at 37 °C.
Detergent phase partitioning of the reaction product was performed
as described in [19].
2.6. Confocal microscopy
HeLa cells grown on coverslips were transfected with 2 μg of the
pDSRed2-ER vector (Clontech, Mountain View, CA) using the Lipo-
fectamine 2000 Reagent (Invitrogen, Carlsbad, CA) according to the
manufacturer's instructions. The pDSRed2-ER vector encodes a
recombinant protein consisting of a Discosoma sp. red ﬂuorescent
protein appended with an amino-terminal signal sequence for co-
translational targeting to the ER lumen and a carboxy-terminal KDEL
ER retention motif. At 24 h post-transfection, cells were exposed for
4 h to 10 μg/ml of a CDT holotoxin containing a GST-tagged CdtB
subunit [17]. The cells were then ﬁxed with 4% paraformaldehyde and
permeabilized with 0.2% Triton X-100 in phosphate buffered saline for
10 min at 22 °C. Non-speciﬁc antibody binding was blocked by
incubation with 3% bovine serum albumin in phosphate buffered
saline for 30min at 22 °C. GST-CdtBwas visualized using a ﬂuorescein-
conjugated goat anti-GST antibody (Abcam, Cambridge, MA) at 1:50
dilution for 30 min at 25 °C. Cells were viewed with a Nikon TE 300
confocal microscope, and images were captured using the Perkin
Elmer (Waltham, MA) UltraViewERS software.
3. Results
3.1. Thermal stability of HdCdtB
Fluorescence spectroscopy and far-UV CD were used to examine
the thermal stability of HdCdtB (Fig. 1), a 29 kDa proteinwith ∼13% α-
helix content and ∼40% β-sheet content [20,21]. Measurements were
conducted with buffer conditions (pH 7.0, 1 mM Ca2+) that
approximated the physiological conditions of the ER (pH 7.2,
0.5 mM Ca2+) [22–25]. Fluorescence spectroscopy detected the solvent
exposure of previously buried aromatic residues by a red shift in the
maximum emission wavelength (Fig. 1A and B). These readings
demonstrated that substantial disordering of the HdCdtB tertiary
structure did not occur at 37 °C. In fact, sample heating to 60 °C was
required to observe the disordering of HdCdtB tertiary structure. Near-
simultaneous measurements of ﬂuorescence and CD spectra were
performed on the same HdCdtB sample in a 4 mm×4 mm optical
path-length rectangular quartz cuvette in order to reduce sample-to-
sample variability. This procedure generated some noise in the far-UV
CD spectra because of the relatively large optical path-length (not
shown). Nevertheless, analysis of the ellipticity at 220 nm (which
reﬂects theα-helical and β-sheet secondary structures) demonstrated
that substantial denaturation of the HdCdtB secondary structure only
occurred at temperatures above 50 °C (Fig. 1C). Thus, signiﬁcant
unfolding of HdCdtB did not occur at physiological temperature. The
conformational changes that occurred at high temperatures were not
completely reversible, as the red shift of the ﬂuorescence spectra andthe reduced ellipticity did not return to their initial values upon
sample cooling to 18 °C (Fig. 1B and C).
3.2. Proteolysis of HdCdtB
The thermal stability of HdCdtB was also examinedwith a protease
sensitivity assay (Fig. 2A). This technique is often used to probe the
folding state of a protein, as properly folded proteins are generally
more resistant to proteolysis than unfolded variants of the same
protein [10,26–28]. To detect temperature-induced changes in the
folding state of HdCdtB, toxin samples were incubated at tempera-
tures ranging from 4 °C to 45 °C for 45 min. The samples were then
placed on ice and incubated with thermolysin for another 45 min at
4 °C. Finally, EDTA and sample buffer were added to halt the
proteolytic digestions. Thermolysin is a calcium-dependent metallo-
protease that hydrolyzes peptide bonds on the amino side of bulky
hydrophobic residues [27]. The use of this speciﬁc protease thus
allowed us to detect temperature-induced conformational changes
that resulted in the exposure of previously buried hydrophobic
residues. For comparative purposes, parallel experiments were run
with the reduced CTA1/CTA2 heterodimer. Reduction of the CTA1/
CTA2 disulﬁde bond normally occurs in the ER of an intoxicated cell
[29]; this event was reproduced in vitro by including 10 mM
β-mercaptoethanol in the assay buffer. Previous work has demon-
strated the complete dissociation of CTA1 from CTA2 under this
reducing condition [12].
HdCdtB exhibited considerable resistance to proteolysis with
thermolysin when incubated at temperatures up to 45 °C. In contrast,
reduced CTA1 was completely degraded at temperatures≥41 °C, and
substantial degradation of the CTA1 sample pre-incubated at 37 °C
was observed as well. Temperatures≥33 °C also induce PT S1 to
assume a thermolysin-sensitive conformation [11]. Thus, at physiolo-
gical temperature CTA1 and PT S1 contain surface-exposed hydro-
phobic residues that could trigger the ERAD translocationmechanism.
HdCdtB, in contrast, exhibited remarkable heat stability and thermo-
lysin resistance when compared to the A chains of other ER-
translocating toxins.
Fig. 3. HdCDT toxicity. (A, B) HeLa cells were incubated with no toxin or with 2 μg/ml
of HdCDT for 2 h in medium alone (control) or medium supplemented with 10%
glycerol. As indicated, one set of cells were pretreated with 10% glycerol medium for
1 h before a further 2 h incubation with glycerol in the absence (no toxin) or presence
of HdCDT. (A) Toxin-induced phosphorylation of histone H2AX was visualized in ﬁxed
cells with a rabbit anti-phospho-H2AX antibody and a FITC-conjugated swine anti-
rabbit IgG antibody. One of two experiments is shown. (B) The graph charts the
average percentage (±range) of nuclei positive for H2AX foci from both experiments.
(C) HeLa cells were incubated with various concentrations of ricin for 4 h in the
absence or presence of 10% glycerol before protein synthesis levels were quantiﬁed.
Measurements taken from unintoxicated cells incubated in the absence or presence of
glycerol were used to establish the 100% value for the corresponding experimental
condition. The average±range of two independent experiments with triplicate
samples is shown.
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ubiquitin-independent degradation by the core 20S proteasome
[11,12]. As the 20S proteasome only acts upon unfolded substrates
[30], toxin processing by this form of the proteasome is likely linked to
thermal instability in the toxin A chain. The relatively heat-stable
nature of HdCdtB would therefore render it resistant to degradation
by the 20S proteasome. To test this prediction, we incubated HdCdtB
or the reduced CTA1/CTA2 heterodimer with the puriﬁed 20S
proteasome (Fig. 2B). Little to no degradation of HdCdtB occurred
during the 20 h time frame of this experiment. In contrast,
degradation of the reduced 21 kDa CTA1 polypeptide was evident at
4 h of incubation and was nearly complete by 8 h of incubation. Thus,
HdCdtB was not an effective substrate for the 20S proteasome.
3.3. Unique features of HdCdtB translocation
Most proteins require at least partial unfolding in order to move
from the ER to the cytosol, yet our data indicated that the isolated
HdCdtB subunit is in a folded conformation at 37 °C. To examine the
role of A chain unfolding in HdCDT intoxication, we performed
toxicity assays with glycerol-treated HeLa cells (Fig. 3). Chemical
chaperones such as glycerol prevent protein unfolding [31] and block
intoxication with ﬁve distinct ER-translocating toxins: ricin [32],
exotoxin A [32], plasmid-encoded toxin [33], CT, and Shiga toxin 2
(Teter et. al, unpublished observations). An inhibition of HdCDT
activity in glycerol-treated cells would therefore suggest that a
chaperone-assisted unfolding step may be necessary for HdCdtB to
reach its target.
Toxicity assays were performed on HdCDT-treated HeLa cells
incubated in the absence or presence of 10% glycerol (Fig. 3A, B). Cells
were exposed to HdCDT and glycerol for a 2 h co-incubation before
screening for toxic effects. In parallel experiments, cells were also pre-
incubated with glycerol for 1 h before a 2 h co-incubationwith HdCDT
and glycerol. Prolonged incubationwith glycerol was toxic to the cells,
so we could not assess HdCDT intoxication by its long-term effect of
cell cycle arrest. Phosphorylation of the histone H2AX has been shown
to occur early in the CDT intoxication process [18] and was therefore
used as an alternative measure of intoxication. Exposure to glycerol
did not prevent the phosphorylation of H2AX in HdCDT-treated cells
(Fig. 3A, B), but it did block intoxication with ricin (Fig. 3C). The latter
result demonstrated that our experimental procedure was sufﬁcient
to inhibit the activity of a prototypical ER-translocating toxin.
Importantly, glycerol treatment alone did not result in the phosphor-
ylation of H2AX (Fig. 3A, B). These collective observations emphasized
the unusual aspects of HdCDT intoxication, a process which may not
require A chain unfolding prior to translocation.
We have previously suggested that HdCdtB may bypass the cytosol
and move directly from the ER to the nucleus [1,3]. This atypical
translocation mechanism would be distinct from the ERAD-mediated
pathway that exports heat-labile toxin A chains to the cytosol. To
further examine this putative translocation route, we generated a
recombinant HdCDT that contains a CVIM-tagged HdCdtB subunit.
The C-terminal CVIM farnesylation motif can serve as an indicator of
protein localization to the cytosol because farnesylation, which
increases the hydrophobicity of the target protein, is a cytosolic
modiﬁcation [34]. The recombinant HdCdtB also contained an
N-terminal GST tag to facilitate protein puriﬁcation and detection.
A farnesylated protein will partition into the detergent phase of
Triton X-114, whereas an unmodiﬁed variant of the same protein will
partition into the aqueous phase. We conﬁrmed that GST-HdCdtB-
CVIM behaved in this predicted manner by performing an in vitro
farnesylation assay. Puriﬁed GST-HdCdtB-CVIM partitioned into the
aqueous phase of Triton X-114 (Fig. 4A, left panel). However, GST-
HdCdtB-CVIM partitioned into the detergent phase of Triton X-114
when it was exposed to the farnesylation machinery present in a
reticulocyte lysate (Fig. 4A, right panel). The farnesylation of GST-HdCdtB-CVIM could therefore be detected by detergent phase
partitioning of the modiﬁed toxin.
For in vivo experiments, we incorporated GST-HdCdtB-CVIM into
a CDT holotoxin. HeLa cells were exposed to 50 μg/ml of the
recombinant holotoxin for 4 h before cell extracts were generated
with a Triton X-114 lysis buffer. As shown in Fig. 4B, GST-HdCdtB-
CVIM could only be found in the aqueous phase of the cell extract.
This indicated that no detectable pool of HdCdtB was modiﬁed by
Fig. 4. HdCdtB translocation. (A) Puriﬁed GST-HdCdtB-CVIM was incubated in the
absence or presence of rabbit reticulocyte lysate before placement in cold 1% Triton X-
114. Aqueous (A) and detergent (D) phases of Triton X-114 were isolated by
centrifugation of the warmed samples. The distribution of GST-HdCdtB-CVIM was
then determined by Western blot analysis of the separate detergent and aqueous
phases. (B) For in vivo farnesylation of GST-HdCdtB-CVIM, HeLa cells were exposed for
4 h to 50 μg/ml of a recombinant CDT holotoxin that contained the GST-HdCdtB-CVIM
subunit. After lysis in 1% Triton X-114, aqueous (A) and detergent (D) phases were
separated. GST-HdCdtB-CVIM was recovered by afﬁnity puriﬁcation and visualized by
Western-blot analysis as described in Materials and methods.
Fig. 5. Intracellular distribution of HdCdtB. Transfected HeLa cells expressing DsRed2-
ER, a ﬂuorescent marker for the ER, were exposed for 4 h to 10 μg/ml of a recombinant
CDT holotoxin that contained a GST-HdCdtB subunit. The cells were then ﬁxed and
stained with a ﬂuorescein-conjugated anti-GST antibody. (A) Labeling patterns for
DsRed2-ER and GST-CdtB from two Z-sections of a single cell. (B) The merged image of
DsRed2-ER and GST-CdtB distributions. Arrows denote the nuclear envelope; arrow-
heads denote invaginations of the nucleoplasmic reticulum.
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HdCdtC heterodimer or to GST-HdCdtB-CVIM alone did not produce
an HdCdtB signal (data not shown). This demonstrated that the
protein detected in vivo was GST-HdCdtB-CVIM and that, as
expected, an intact holotoxin was required to deliver GST-HdCdtB-
CVIM into the target cell. Given the robust HdCdtB signal present in
the aqueous phase of the HeLa cell extract, any trace amount of
farnesylated GST-HdCdtB-CVIM would represent an exceedingly
small pool of the total protein.
Methods such as Western blot analysis that directly monitor the
toxin itself are less sensitive than toxicity assays and therefore require
higher toxin doses for experimentation. Thus, it was necessary to use
25-fold more HdCDT for the farnesylation assay than for the toxicity
assay of Fig. 3. The relatively short-term intoxication periods of 2–4 h
for our in vivo experiments also required the use of high toxin
concentrations. In our previous work, a 4 h exposure to 20 μg/ml of
HdCDT was required to detect sulfation and mannosylation of the
recombinant HdCdtB subunit [3]. This toxin concentration did not
alter the cellular responses in terms of biochemical signaling.
Likewise, the 4 h exposure to 50 μg /ml of toxin that was required
for our farnesylation assay did not alter the cell morphology as
determined by actin and nuclear staining. Furthermore, the cellular
distension that is only seen after long-term intoxications was not
observed in cells exposed to 50 μg/ml of HdCDT for 4 h. Collectively,
these observations indicated that the high toxin concentration
required for our farnesylation assay did not alter the cellular response
to HdCDT intoxication.
A direct ER-to-nucleoplasm translocation route would bypass the
cytosolic farnesylation machinery and therefore leave HdCdtB in an
unmodiﬁed state. Confocal microscopy was used to further examine
this putative translocation route (Fig. 5). HeLa cells were exposed for
4 h to 10 μg/ml of a recombinant CDT holotoxin that contained a GST-
tagged CdtB subunit [17]. The cellular location of GST-CdtB was then
compared to the distribution of DsRed2-ER, a ﬂuorescent marker for
the ER. GST-CdtB and DsRed2-ER could be found in a branching,
tubularized network that was contiguous with the nuclear envelope
(arrows). GST-CdtB could also be found in the nucleus but could not be
detected in the cytosol. As with the farnesylation data, this suggested
that HdCdtB bypasses the cytosol and moves directly from the ER to
the nucleus. Finally, GST-CdtB and DsRed2-ER were visualized in
invaginations of the nuclear envelope that protruded into the nucleus
(arrowheads). These structures have been previously visualized in
unintoxicated cells and are morphologically deﬁned as the nucleo-
plasmic reticulum [35–37]. By visualizing DsRed2-ER in unintoxicated
HeLa cells, we conﬁrmed that the tubular protrusions were a normal
cellular structure rather than a byproduct of HdCDT intoxication and
that the DsRed2-ER signal did not bleed into the ﬂuorescein channel
used to visualize GST-CdtB (not shown). Localization to the nucleo-
plasmic reticulum (i.e., the nuclear protrusions) has not been reported
for other toxins that have been visualized in the ER [19,24,38–40]. Thisagain emphasized the unique aspects of HdCDT intoxication. The
functional relevance of these nuclear protrusions in regards to CDT
intoxication has yet to be determined.
4. Discussion
CDTs are produced by numerous Gram-negative pathogens [1].
They are the only known bacterial AB toxins that function primarily by
direct damage to the host cell DNA. CdtB accordingly acts within the
nucleus, whereas other toxin A chains act within the cytosol. Our
current study demonstrates that, in addition to its unique target and
unique site of action, CdtB also exhibits unique structural properties
which affect its interaction with the host cell and distinguish it from
the A chains of other ER-translocating toxins.
With the exception of the Salmonella Typhi CDT [41], the family of
CDTs are tripartite toxins composed of a cell-binding CdtA/CdtC
subunit and a catalytic CdtB subunit. Both CdtA and CdtC are required
for the optimal biological activity of CDT, but the two proteins do not
appear to play equivalent roles in cell binding and cellular uptake
[1,42–46]. Although the exact roles of CdtA and CdtC in toxin
endocytosis and intracellular trafﬁcking remain to be determined, it
is well-established that CdtB must exit the endomembrane system
and reach the nucleus in order to elicit a cytotoxic effect [2,3,45,47].
HdCdtB escape from the endomembrane system occurs at the level of
the ER and involves an ERAD-independent mechanism or an ERAD
mechanism that is signiﬁcantly different from the pathway utilized by
other ER-translocating toxins [3].
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cytosol [4,5]. For three of these toxins – CT, PT, and ricin – thermal
instability in the isolated catalytic subunit may activate the ERAD
mechanism [10–12]. The heat-labile nature of the toxin A chain could
also facilitate its ubiquitin-independent degradation by the 20S
proteasome. Our results provide previously unknown evidence that
HdCdtBmaintains its folded conformation at 37 °C in buffer conditions
that mimic the physiology of the ER. This offers a structural basis for
the previously reported ERAD-independent mechanism of HdCdtB
export from the ER [3]: since HdCdtB does not unfold at 37 °C, it is not
recognized as an ERAD substrate. The thermal stability of HdCdtB also
protects it from degradation by the 20S proteasome, a proteolytic
machine that can only act upon unfolded proteins. Finally, CDT is the
only known ER-translocating toxin that can function in glycerol-
treated cells. The structural and cellular events involved with HdCdtB
export from the ER are therefore distinct from those events involving
other ER-translocating toxins.
The productive intoxication of glycerol-treated cells suggests that
HdCdtB unfolding is not required for its exit from the ER. It is
structurally feasible for HdCdtB to exit the ER in a folded state, as
passage of folded proteins through the Sec61 translocon pore has
been documented [48]. The translocon, which can dilate to 60 Å in
diameter [49], could accommodate the 45 Å diameter of an isolated,
folded CdtB subunit [50]. Flexibility in the structure of CdtB [50]
could also allow the folded toxin to assume a conformation suitable
for passage through the Sec61p translocon or other pores in the ER
membrane.
Our data further suggest that HdCdtB follows a unique transloca-
tion route involving direct passage from the ER to the nucleus.
However, we cannot currently discount the possibility that HdCdtB
ﬁrst enters the cytosol and then rapidly moves into the nucleus
through the nuclear pore complex. Atypical nuclear localization
sequences in other CdtB subunits [51,52] are often used as evidence
for a cytosol-to-nucleus transport route, but these sequences could
also serve as retrieval motifs to return an escaped pool of toxin to the
nucleus. Likewise, the KDEL motif in CT is thought to act as an ER
retentionmotif rather than as a primary ER targeting motif [53]. Given
the many unique aspects of HdCdtB translocation, we favor the ER-to-
nucleus model of HdCdtB translocation and are currently working to
deﬁne the molecular details of this process.
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